COMPASS Pathways plc

FSX : 5Y6

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Information

Sector
Healthcare
Industry
Medical Care Facilities
Type
Common Stock
Country
United Kingdom

Price

EUR 5.50

Symbol

5Y6

Type

Common Stock

Previous Close

:

5.45

52 Week Range

:

4.84 - 11.70

Volume

:

133.00

Average Volume

:

147.00

High

:

5.50

Low

:

5.15

Change

:

0.05

Percent change (%)

:

0.92

Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...